We are live on
!
Find out more
ONC
BeOne Medicines Ltd
ONC
ONC
57 hedge funds and large institutions have $918M invested in BeOne Medicines Ltd in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
42% more capital invested
Capital invested by funds: $645M → $918M (+$273M)
41% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 17
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
2% more funds holding
Funds holding: 56 → 57 (+1)
0.54% more ownership
Funds ownership: 3.4% → 3.93% (+0.54%)
Holders
57
Holders Change
+1
Holders Change %
+1.79%
% of All Funds
1.42%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.15%
New
10
Increased
24
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$92.8M |
| 2 |
O
OppenheimerFunds
New York
|
+$26M |
| 3 |
O
OrbiMed
New York
|
+$15.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.9M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$6.46M |
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$9.85M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.79M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$6.35M |
| 4 |
QF
QVT Financial
New York
|
-$6.22M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.12M |
